drug
entacapone
Marketedupdated 3mo agoby AvKare LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugSINEMET CR11 co-mentions · 2 sources
- druglevodopa10 co-mentions · 2 sources
- druglevodopa CR10 co-mentions · 2 sources
- drugINBRIJA10 co-mentions · 2 sources
- companyRising Pharma Holdings Inc3 co-mentions · 1 sources
- tagRecall3 co-mentions · 1 sources
- tagApproval2 co-mentions · 1 sources
- tagSmall Molecule1 co-mentions · 1 sources
indications
investigational
Parkinson's Disease
all catalysts(0)
nothing on the calendar yet
Trials studying entacapone
- phase2A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients
- phase1A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients
- phase2An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 48m ago
Found something off?
comments(0)
5-min edit window · permanent after that